Tempus’ Quest for a Cancer-free America Under Eric Lefkofsky

Co-founder and Chief Executive Officer of Tempus, Eric Lefkofsky is an American businessman born on September 2, 1969. He is the chairman and co-founder of Groupon, co-founder of Mediaocean, Lightbank, Echo Global Logistics and InnerWorkings. Eric Lefkofsky was born in Detroit but raised in Southfiled, Michigan, United States of America. His father, Bill, was a structural engineer while his mother Sandy was a teacher. Eric Lefkofsky attended the Southfield- Lathrup High School and graduated in 1987. After graduation, Mr. Eric attended the University of Michigan where he successfully completed course graduating with honors in 1991. He furthered his education at the University of Michigan Law School and in 1993 Eric Lefkofsky earned a Juris Doctor.

Eric Lefkofsky began his entrepreneurial ventures way back when he was still in University, selling carpets at the University of Michigan. In 1993, that was after he was through with law school, Eric came together with his friend Brad Keywell to buy a company. The firm was known as Brandon Apparel and was located in Madison, Wisconsin. Over the years, Eric Lefkofsky has worked hard to get to where he is today. He has co-founded and chaired a number of companies like Uptake LLC, which is an analytics company.

In 2016, Eric Lefkofsky, who is also the current chief executive officer, founded Tempus. This is simply a technology driven firm enabling physicians to offer cancer care to patients at a personalized level. According to a study carried out by the National Cancer Institute in America in 2014 over 14 million people in the U.S. are living with cancer. By 2024 the number is projected to rocket to 19 million. Tempus on the other hand is doing its best to carry out tests and come up with solutions to prevent for health this from happening. Recently the firm has made huge progress in its research. Tempus has developed a means to analyze a patient’s clinical and medical data. The firm does through collecting molecular data. Molecular data is simply genomic information and is acquired through human genome sequencing. Eric Lefkofsky and his team of experts are working tirelessly to come up with customized cancer therapies that will be affordable to all.

To know more visit @: http://lefkofskyfoundation.com/

Lefkofsky Family Foundation – Enhancing the Human Life Quality

The Chief Executive Officer Of Tempus is Mr. Eric Lefkofsky. It is a great technology firm that fights cancer. He is also a partner of a venture fund that invests in innovative technologies. He is the founder of Groupon which is a trusted e-commerce marketplace.

Mr. Lefkofsy has been instrumental in forming a private charitable foundation. He is a Trustee in Chicago in the Lurie Children’s Hospital. Mr. Lefkofsky is also a professor at the Chicago University. He has successfully finished his graduation from Michigan University.

Mr. Lefkofsky was self-motivated to Start Tempus. It happened when his wife was found to have cancer of the breast. The primary purpose behind Tempus to create a technology layer in a current electronic medical record. His main goal is to make the people get familiar with oncology. They can utilize the platform to gather data for the purpose of analysis for disorders associated to neurology.

Mr. Lefkofsky’s foundation’s main aim is to have great programs and research that improve the human life’s quality in the different communities. The option of grants is there in many critical areas like human rights, medical research, culture, and arts. Click here to know more.

MrLefkofsky used to sell carpets as a freshman in Michigan University. He and his business partner Keywell initiated a web firm, Starbelly that had immense specialization in promoting various products. He created Groupon that is considered the finest in the technology industry.

Mr. Lefkofsky has exhibited a broad range of philanthropy. The Lefkofsky family foundation has become active partners with Google and Motorola Mobility Foundation. It has played a pivotal role in handling issues that are beyond Chicago.

Mr. Lefkofsky’s family foundation is a charitable organization that came into existence in the year 2006. It provides extensive research and also great programs to improve the human being’s quality of life.

His foundation makes a great effort to ensure there is access to high-quality education and also expanding of various cultural initiatives. Mr. Eric Lefkofsky’s family foundation strives to improve the human life quality to a great extent. Mr. Eric Lefkofsky is the greatest American entrepreneur of all times.

Omar Boraie Is One Of New Brunswick, New Jersey’s Favorite Sons

New Brunswick, New Jersey became a pharmaceutical town in 1885. That’s when the two Johnson brothers started doing business in the city. Johnson and Johnson established a home office in downtown New Brunswick in 1886, and the world’s largest healthcare product manufacturer never left the city. The population of the inner-city grew, thanks to the immigrants that settled in the Middlesex County town. The industrial revolution grew along the East Coast, and New Brunswick diverse spirit of community was born.

Today, the largest medical school in the country is located in New Brunswick. Two teaching hospitals and the Rutgers University Cancer Institute are also part of the community. The Robert Wood Johnson University Hospital is considered one of the leading teaching, if not the leading teaching hospital, in New Jersey. The Rutgers University Cancer Institute is considered the leading precision medicine and genomic science center in the country.

The Rutgers Cancer Institute recently established the Omar Boraie Chair in genomic science, according to an article published by newswise.com. Boraie is one of New Brunswick’s favorite sons. He is credited with helping downtown New Brunswick transform into the “Healthcare City” it is today. Boraie’s company built several high-rise office and residential buildings downtown. His dedication to urban renewal got the attention of city officials and the governor back in the 1970s. The first Boraie office building, Albany Plaza One was completed in 1983. Plaza Two opened in 2003, and Plaza Three is on the drawing board.

Omar Boraie has always been interested in science. He is a chemist, as well as, a real estate developer. When the opportunity to sponsor an endowment chair at the Rutgers Cancer Institute presented itself, he didn’t waste any time pledging the $1.5 million to secure the chair. His pledge was matched by an anonymous donor. The Rutgers ’18 Endowment Chair Challenge campaign is raising $54 million for research. The research is focused on treating cancer at the genetic level. Individual treatments for different subpopulations of cancer is the future of cancer treatments, and according to Patch.com the Rutgers Cancer Institute is on the cutting edge of this medical breakthrough.

Boraie is known for his philanthropic endeavors. Omar has made several contributions to organizations that help the community. But he is especially proud of his connection with the Rutgers Cancer Institute. At this stage of his life, helping to find a treatment for everyone suffering from cancer is one of his priorities.

Reference: https://www.bloomberg.com/profiles/companies/0601263D:US-boraie-development-llc

New Personalized Cancer Treatments Show Promise

Tailor made cancer treatments, it might sound like something out of science fiction – but, in reality its’ here today in the United States. The exciting treatment is in it’s earliest stages of clinic trials. The treatment is designed around programming the users own white blood cells to seek out and attack cancer agents. The treatment is delivered in the form of a vaccine and has positive results with the few patients it has been tested on.

Dr. Beatriz Carreno, according to the BBC, states the findings represent a significant step towards treating patients with personalized immunology-therapies.

While the excitement of the new treatment options has everyone at Bulletproof Coffee excited, there are still several hurdles for the treatment to pass. The first is carefully controlled clinical trials which must show that boosting the immune system through personalized vaccines makes a positive and noticeable difference towards treating tumors.

The second step is producing working methods that are both cost and time effective. Since each vaccine must be produced from the patient’s own cancer cells the cost to do so is enormous and may delay the treatment process.

Hypothesis shows that highly mutated cancers such as stage 4 breast cancers and lung cancers will benefit from a treatment similar to this.